Subject Index
Book:
Frontiers in Cardiovascular Drug Discovery
Page:
249-256
Author(s):
Atta ur-Rahman and M. Iqbal Choudhary
List of Contributors
Book:
Frontiers in Cardiovascular Drug Discovery
Page:
iii-iv
Author(s):
Atta ur-Rahman and M. Iqbal Choudhary
Preface
Book:
Frontiers in Cardiovascular Drug Discovery
Page:
ii-iii
Author(s):
Atta ur-Rahman and M. Iqbal Choudhary
Index
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
289-309
Author(s):
Atta-ur-Rahman
Topical Drugs for Diabetic Complications Current and Future
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
211-288
Author(s):
Ryuhei Sano and Tomohiko Sasase
Drugs and the Peroxisome Proliferator Activated Receptors
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
149-210
Author(s):
Kevin Stuart, Andrew Hartland, Mithun Bhartia and Sudarshan Ramachandran
MicroRNA, A Diligent Conjurer in the Exposition of Diabetes
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
121-148
Author(s):
Puneetpal Singh
Liraglutide: Present and Future
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
67-120
Author(s):
Dan Mircea Cheţa, Cristian Serafinceanu and Cornelia Zetu
New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
33-66
Author(s):
Emilia Liao, Agustin Busta, Ashutosh Pareek and Leonid Poretsky
Angiotensin Blockers and Renoprotection in Diabetic Chronic Kidney Disease is a Failed Paradigm? – A Revisionist View of Renoprotection in Diabetic Chronic Kidney Disease and A Novel Classification Scheme for Renoprotective Agents
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
3-32
Author(s):
Macaulay A.C. Onuigbo